Nissui Corporation
Nissui Corporation (NISUY) Financial Performance & Income Statement Overview
Explore the financials of Nissui Corporation (NISUY), including yearly and quarterly data on income, cash flow, and balance sheets.
Nissui Corporation (NISUY) Income Statement & Financial Overview
View the income breakdown for Nissui Corporation NISUY across both annual and quarterly reports.
| Metric | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| Revenue | $222.66B | $220.04B | $220.64B | $205.89B |
| Cost of Revenue | $188.14B | $185.17B | $184.78B | $178.50B |
| Gross Profit | $34.52B | $34.87B | $35.87B | $27.40B |
| Gross Profit Ratio | $0.16 | $0.16 | $0.16 | $0.13 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $1.15B |
| SG&A Expenses | $26.95B | $27.32B | $26.14B | $20.48B |
| Operating Expenses | $26.95B | $27.32B | $26.14B | $20.48B |
| Total Costs & Expenses | $215.09B | $212.49B | $210.92B | $198.98B |
| Interest Income | $0.00 | $0.00 | $133.00M | $0.00 |
| Interest Expense | $0.00 | $0.00 | $807.00M | $497.00M |
| Depreciation & Amortization | $5.71B | $6.19B | $5.71B | $6.22B |
| EBITDA | $13.27B | $13.74B | $15.43B | $6.32B |
| EBITDA Ratio | $0.06 | $0.06 | $0.07 | $0.03 |
| Operating Income | $7.56B | $7.55B | $9.72B | $6.92B |
| Operating Income Ratio | $0.03 | $0.03 | $0.04 | $0.03 |
| Other Income/Expenses (Net) | $5.09B | $243.00M | -$645.00M | $2.30B |
| Income Before Tax | $12.66B | $7.79B | $9.08B | $5.60B |
| Income Before Tax Ratio | $0.06 | $0.04 | $0.04 | $0.03 |
| Income Tax Expense | $3.15B | $1.94B | $3.46B | $1.84B |
| Net Income | $9.08B | $5.21B | $5.29B | $3.56B |
| Net Income Ratio | $0.04 | $0.02 | $0.02 | $0.02 |
| EPS | $292.10 | $167.60 | $170.20 | $114.30 |
| Diluted EPS | $292.10 | $167.60 | $170.20 | $114.30 |
| Weighted Avg Shares Outstanding | $31.08M | $31.08M | $31.08M | $31.11M |
| Weighted Avg Shares Outstanding (Diluted) | $31.08M | $31.08M | $31.08M | $31.11M |
The company's financials show resilient growth, with revenue advancing from $205.89B in Q4 2024 to $222.66B in Q3 2025. Gross profit remained healthy with margins at 16% in Q3 2025 compared to 13% in Q4 2024. Operating income hit $7.56B last quarter, sustaining a consistent 3% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $13.27B. Net income rose to $9.08B, while earnings per share reached $292.10. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan